Aldo-keto Reductase 1B15 (AKR1B15): A mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates

Journal of Biological Chemistry

Volumn 290, Issue 10, 2015, Pages 6531-6545

  Weber, Susanne ^a   Salabei, Joshua K ^b   Möller, Gabriele ^a   Kremmer, Elisabeth ^a   Bhatnagar, Aruni ^b   Adamski, Jerzy ^a,c,d   Barski, Oleg A ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b University of Louisville School of Medicine   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL CULTURE; ENZYMES; GENE EXPRESSION; GENES; HISTOLOGY; MITOCHONDRIA; PROTEINS; SUBSTRATES; TISSUE;

ALDO-KETO REDUCTASE; ALTERNATIVE SPLICING; AMINO ACID RESIDUES; ENZYMATIC ACTIVITIES; EXPRESSION LEVELS; HYDROXYSTEROID DEHYDROGENASE; POSITIONAL SELECTIVITY; SUBCELLULAR LOCALIZATIONS;

ENZYME ACTIVITY;

3 KETO ACYL COENZYME A; ACYL COENZYME A; ALDO KETO REDUCTASE 1B15.1; ALDO KETO REDUCTASE 1B15.2; ISOPROTEIN; MESSENGER RNA; OXIDOREDUCTASE; RECOMBINANT ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; AKR1B15 PROTEIN, HUMAN;

ADIPOSE TISSUE; ALDO KETO REDUCTASE 1B15 GENE; ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PURIFICATION; ENZYME SUBSTRATE; GENE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MITOCHONDRION; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; TESTIS; TISSUE DISTRIBUTION; UPREGULATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; KINETICS; METABOLISM; OXIDATION REDUCTION REACTION;

ACYL COENZYME A; ADIPOSE TISSUE; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KINETICS; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDOREDUCTASES ACTING ON ALDEHYDE OR OXO GROUP DONORS; PROTEIN ISOFORMS; STEROIDS;

EID: 84925002765     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.610121     Document Type: Article

References (73)

1. Penning, T. M., and Drury, J. E. (2007) Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Arch. Biochem. Biophys. 464, 241-250
2. Barski, O. A., Tipparaju, S. M., and Bhatnagar, A. (2008) The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metab. Rev. 40, 553-624
3. Kondo, K. H., Kai, M. H., Setoguchi, Y., Eggertsen, G., Sjöblom, P., Setoguchi, T., Okuda, K. I., and Björkhem, I. (1994) Cloning and expression of cDNA of human δ4-3-oxosteroid 5β-reductase and substrate specificity of the expressed enzyme. Eur. J. Biochem. 219, 357-363
4. Fujii, Y., Watanabe, K., Hayashi, H., Urade, Y., Kuramitsu, S., Kagamiyama, H., and Hayaishi, O. (1990) Purification and characterization of ρ-crystallin from Japanese common bullfrog lens. J. Biol. Chem. 265, 9914-9923
5. Weng, J., Cao, Y., Moss, N., and Zhou, M. (2006) Modulation of voltage-dependent Shaker family potassium channels by an aldo-keto reductase. J. Biol. Chem. 281, 15194-15200
6. Barski, O. A., Papusha, V. Z., Ivanova, M. M., Rudman, D. M., and Finegold, M. J. (2005) Developmental expression and function of aldehyde reductase in proximal tubules of the kidney. Am. J. Physiol. Renal Physiol. 289, F200-F207
7. Penning, T. M. (2011) Human hydroxysteroid dehydrogenases and prereceptor regulation: insights into inhibitor design and evaluation. J. Steroid Biochem. Mol. Biol. 125, 46-56
8. Kabututu, Z., Manin, M., Pointud, J.-C., Maruyama, T., Nagata, N., Lambert, S., Lefranc¸ois-Martinez, A.-M., Martinez, A., and Urade, Y. (2009) Prostaglandin F2α synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. J. Biochem. 145, 161-168
9. Lemonde, H. A., Custard, E. J., Bouquet, J., Duran, M., Overmars, H., Scambler, P. J., and Clayton, P. T. (2003) Mutations in SRD5B1 (AKR1D1), the gene encoding δ(4)-3-oxosteroid 5β-reductase, in hepatitis and liver failure in infancy. Gut 52, 1494-1499
10. Lyon, R. C., Johnston, S. M., Watson, D. G., McGarvie, G., and Ellis, E. M. (2007) Synthesis and catabolism of γ-hydroxybutyrate in SH-SY5Y human neuroblastoma cells: role of the aldo-keto reductase AKR7A2. J. Biol. Chem. 282, 25986-25992
11. Srivastava, S., Chandra, A., Ansari, N. H., Srivastava, S. K., and Bhatnagar, A. (1998) Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal. Biochem. J. 329, 469-475
12. Baba, S. P., Barski, O. A., Ahmed, Y., O'Toole, T. E., Conklin, D. J., Bhatnagar, A., and Srivastava, S. (2009) Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue. Diabetes 58, 2486-2497
13. Guengerich, F. P., Cai, H., McMahon, M., Hayes, J. D., Sutter, T. R., Groopman, J. D., Deng, Z., and Harris, T. M. (2001) Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases. Chem. Res. Toxicol. 14, 727-737
14. Maser, E. (2004) Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK. Trends Pharmacol. Sci. 25, 235-237
15. Liu, S.-Q., Jin, H., Zacarias, A., Srivastava, S., and Bhatnagar, A. (2001) Binding of pyridine coenzymes to the β-subunit of the voltage sensitive potassium channels. Chem. Biol. Interact. 130, 955-962
16. Malup, T. K., Kobzev, V. F., Zhdanova, L. G., Slobodianiuk, Si., and Sviridov, S. M. (2000) [Analysis of nucleotide sequences in a region of S100b protein gene in AKR/J, DBA/dJ and BALB/cLac mice]. Mol. Biol. (Mosk.) 34, 366-367
17. Ramana, K. V. (2011) Aldose reductase: new insights for an old enzyme. Biomol. Concepts 2, 103-114
18. Vikramadithyan, R. K., Hu, Y., Noh, H.-L., Liang, C.-P., Hallam, K., Tall, A. R., Ramasamy, R., and Goldberg, I. J. (2005) Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J. Clin. Invest. 115, 2434-2443
19. Gabbay, K. H. (2004) Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004? Curr. Diab. Rep. 4, 405-408
20. Dvornik, E., Simard-Duquesne, N., Krami, M., Sestanj, K., Gabbay, K. H., Kinoshita, J. H., Varma, S. D., and Merola, L. O. (1973) Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor. Science 182, 1146-1148
21. Kinoshita, J. H. (1990)Athirty year journey in the polyol pathway. Exp. Eye Res. 50, 567-573
22. Bril, V., and Buchanan, R. A. (2006) Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy. Diabetes Care 29, 68-72
23. st century. Curr. Med. Chem. 16, 734-752
24. Srivastava, S., Spite, M., Trent, J. O., West, M. B., Ahmed, Y., and Bhatnagar, A. (2004) Aldose reductase-catalyzed reduction of aldehyde phospholipids. J. Biol. Chem. 279, 53395-53406
25. Vander Jagt, D. L., Robinson, B., Taylor, K. K., and Hunsaker, L. A. (1992) Reduction of trioses by NADPH-dependent aldo-keto reductases: aldose reductase, methylglyoxal, and diabetic complications. J. Biol. Chem. 267, 4364-4369
26. Srivastava, S., Vladykovskaya, E., Barski, O. A., Spite, M., Kaiserova, K., Petrash, J. M., Chung, S. S., Hunt, G., Dawn, B., and Bhatnagar, A. (2009) Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice. Circ. Res. 105, 793-802
27. Shinmura, K., Bolli, R., Liu, S.-Q., Tang, X.-L., Kodani, E., Xuan, Y. T., Srivastava, S., and Bhatnagar, A. (2002) Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ. Res. 91, 240-246
28. Ramana, K. V., Chandra, D., Srivastava, S., Bhatnagar, A., Aggarwal, B. B., and Srivastava, S. K. (2002) Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J. Biol. Chem. 277, 32063-32070
29. Cao, D., Fan, S. T., and Chung, S. S. M. (1998) Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273, 11429-11435
30. Hyndman, D. J., and Flynn, T. G. (1998) Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim. Biophys. Acta 1399, 198-202
31. Gallego, O., Belyaeva, O. V., Porté, S., Ruiz, F. X., Stetsenko, A. V., Shabrova, E. V., Kostereva, N. V., Farrés, J., Parés, X., and Kedishvili, N. Y. (2006) Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids. Biochem. J. 399, 101-109
32. Yoshitake, H., Takahashi, M., Ishikawa, H., Nojima, M., Iwanari, H., Watanabe, A., Aburatani, H., Yoshida, K., Ishi, K., Takamori, K., Ogawa, H., Hamakubo, T., Kodama, T., and Araki, Y. (2007) Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer 17, 1300-1306
33. Martin, H.-J., Breyer-Pfaff, U., Wsol, V., Venz, S., Block, S., and Maser, E. (2006) Purification and characterization of AKR1B10 from human liver: role in carbonyl reduction of xenobiotics. Drug Metab. Dispos. 34, 464-470
34. Zhong, L., Shen, H., Huang, C., Jing, H., and Cao, D. (2011) AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group. Toxicol. Appl. Pharmacol. 255, 40-47
35. Salabei, J. K., Li, X.-P., Petrash, J. M., Bhatnagar, A., and Barski, O. A. (2011) Functional expression of novel human and murine AKR1B genes. Chem. Biol. Interact. 191, 177-184
36. Wabitsch, M., Brenner, R. E., Melzner, I., Braun, M., Möller, P., Heinze, E., Debatin, K. M., and Hauner, H. (2001) Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int. J. Obes. Relat. Metab. Disord. 25, 8-15
37. Schmitt, S., Saathoff, F., Meissner, L., Schropp, E.-M., Lichtmannegger, J., Schulz, S., Eberhagen, C., Borchard, S., Aichler, M., Adamski, J., Plesnila, N., Rothenfusser, S., Kroemer, G., and Zischka, H. (2013) A semi-automated method for isolating functionally intact mitochondria from cultured cells and tissue biopsies. Anal. Biochem. 443, 66-74
38. Mindnich, R., Haller, F., Halbach, F., Moeller, G., Hrabé de Angelis, M., and Adamski, J. (2005) Androgen metabolism via 17β-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme. J. Mol. Endocrinol. 35, 305-316
39. Barski, O. A., Gabbay, K. H., Grimshaw, C. E., and Bohren, K. M. (1995) Mechanism of human aldehyde reductase: characterization of the active site pocket. Biochemistry 34, 11264-11275
40. Bannai, H., Tamada, Y., Maruyama, O., Nakai, K., and Miyano, S. (2002) Extensive feature detection of N-terminal protein sorting signals. Bioinformatics 18, 298-305
41. Barski, O. A., Mindnich, R., and Penning, T. M. (2013) Alternative splicing in the aldo-keto reductase superfamily: implications for protein nomenclature. Chem. Biol. Interact. 202, 153-158
42. Wilson, D. K., Bohren, K. M., Gabbay, K. H., and Quiocho, F. A. (1992) An unlikely sugar substrate site in the 1.65 Å structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science 257, 81-84
43. Gallego, O., Ruiz, F. X., Ardèvol, A., Domínguez, M., Alvarez, R., de Lera, A. R., Rovira, C., Farrés, J., Fita, I., and Parés, X. (2007) Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc. Natl. Acad. Sci. U.S.A. 104, 20764-20769
44. + channel β1 gene and functional expression of the β2 gene product. FEBS Lett. 370, 32-36
45. Pongs, O., and Schwarz, J. R. (2010) Ancillary subunits associated with voltage-dependent K+ channels. Physiol. Rev. 90, 755-796
46. Puranen, T. J., Poutanen, M. H., Peltoketo, H. E., Vihko, P. T., and Vihko, R. K. (1994) Site-directed mutagenesis of the putative active site of human 17β-hydroxysteroid dehydrogenase type 1. Biochem. J. 304, 289-293
47. Byrns, M. C., Jin, Y., and Penning, T. M. (2011) Inhibitors of type 5 17β- hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights. J. Steroid Biochem. Mol. Biol. 125, 95-104
48. Luu-The, V., Tremblay, P., and Labrie, F. (2006) Characterization of type 12 17β-hydroxysteroid dehydrogenase, an isoform of type 3 17β-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol. Endocrinol. 20, 437-443
49. Endo, S., Matsunaga, T., Mamiya, H., Ohta, C., Soda, M., Kitade, Y., Tajima, K., Zhao, H.-T., El-Kabbani, O., and Hara, A. (2009) Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids. Arch. Biochem. Biophys. 487, 1-9
50. Keller, B., Meier, M., and Adamski, J. (2009) Comparison of predicted and experimental subcellular localization of two putative rat steroid dehydrogenases from the short-chain dehydrogenase/reductase protein superfamily. Mol. Cell. Endocrinol. 301, 43-46
51. Alías, M., Ayuso-Tejedor, S., Fernández-Recio, J., Cativiela, C., and Sancho, J. (2010) Helix propensities of conformationally restricted amino acids: non-natural substitutes for helix breaking proline and helix forming alanine. Org. Biomol. Chem. 8, 788-792
52. Lam, C.-W., Yuen, Y.-P., Cheng, W.-F., Chan, Y.-W., and Tong, S.-F. (2006) Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome. Clin. Chim. Acta 364, 256-259
53. Keenan, C., Ghaffar, S., Grant, A. W., Hinshelwood, A., Li, D., McGarvie, G., and Ellis, E. M. (2006) in Enzymology and Molecular Biology of Carbonyl Metabolism, Vol. 12 (Weiner, H., Plapp, B., Lindahl, R., and Maser, E., eds) pp. 388-395, Purdue University Press, West Lafayette, IN
54. Kelly, V. P., Sherratt, P. J., Crouch, D. H., and Hayes, J. D. (2002) Novel homodimeric and heterodimeric rat γ-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins. Biochem. J. 366, 847-861
55. Mindnich, R., Möller, G., and Adamski, J. (2004) The role of 17β-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 218, 7-20
56. Peltoketo, H., Luu-The, V., Simard, J., and Adamski, J. (1999) 17β-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family: nomenclature and main characteristics of the 17HSD/KSR enzymes. J. Mol. Endocrinol. 23, 1-11
57. Shafqat, N., Marschall, H.-U., Filling, C., Nordling, E., Wu, X.-Q., Björk, L., Thyberg, J., Mårtensson, E., Salim, S., Jörnvall, H., and Oppermann, U. (2003) Expanded substrate screenings of human and Drosophila type 10 17β-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3α/7α/7β/17β/20β/21-H. Biochem. J. 376, 49-60
58. Clayton, P. T., Eaton, S., Aynsley-Green, A., Edginton, M., Hussain, K., Krywawych, S., Datta, V., Malingre, H. E. M., Berger, R., and van den Berg, I. E. T. (2001) Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. J. Clin. Invest. 108, 457-465
59. Heslegrave, A. J., and Hussain, K. (2013) Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase. J. Clin. Endocrinol. Metab. 98, 496-501
60. Schulz, N., Himmelbauer, H., Rath, M., van Weeghel, M., Houten, S., Kulik, W., Suhre, K., Scherneck, S., Vogel, H., Kluge, R., Wiedmer, P., Joost, H.-G., and Schürmann, A. (2011) Role of medium- and short-chain L-3- hydroxyacyl-CoA dehydrogenase in the regulation of body weight and thermogenesis. Endocrinology 152, 4641-4651
61. Yang, S.-Y., He, X.-Y., and Schulz, H. (2005) 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease. FEBS J. 272, 4874-4883
62. Miller, W. L., and Auchus, R. J. (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32, 81-151
63. Yang, S.-H., Liu, R., Perez, E. J., Wen, Y., Stevens, S. M., Jr., Valencia, T., Brun-Zinkernagel, A.-M., Prokai, L., Will, Y., Dykens, J., Koulen, P., and Simpkins, J. W. (2004) Mitochondrial localization of estrogen receptor β. Proc. Natl. Acad. Sci. U.S.A. 101, 4130-4135
64. Vasconsuelo, A., Milanesi, L., and Boland, R. (2013) Actions of 17β-estradiol and testosterone in the mitochondria and their implications in aging. Ageing Res. Rev. 12, 907-917
65. Pedram, A., Razandi, M., Wallace, D. C., and Levin, E. R. (2006) Functional estrogen receptors in the mitochondria of breast cancer cells. Mol. Biol. Cell 17, 2125-2137
66. Demonacos, C., Djordjevic-Markovic, R., Tsawdaroglou, N., and Sekeris, C. E. (1995) The mitochondrion as a primary site of action of glucocorticoids: the interaction of the glucocorticoid receptor with mitochondrial DNA sequences showing partial similarity to the nuclear glucocorticoid responsive elements. J. Steroid Biochem. Mol. Biol. 55, 43-55
67. Demonacos, C. V., Karayanni, N., Hatzoglou, E., Tsiriyiotis, C., Spandidos, D. A., and Sekeris, C. E. (1996) Mitochondrial genes as sites of primary action of steroid hormones. Steroids 61, 226-232
68. Yashin, A. I., Wu, D., Arbeev, K. G., and Ukraintseva, S. V (2010) Joint influence of small-effect genetic variants on human longevity. Aging 2, 612-620
69. Witkowski, A., Joshi, A. K., and Smith, S. (2007) Coupling of the de novo fatty acid biosynthesis and lipoylation pathways in mammalian mitochondria. J. Biol. Chem. 282, 14178-14185
70. Hiltunen, J. K., Schonauer, M. S., Autio, K. J., Mittelmeier, T. M., Kastaniotis, A. J., and Dieckmann, C. L. (2009) Mitochondrial fatty acid synthesis type II: more than just fatty acids. J. Biol. Chem. 284, 9011-9015
71. Parl, A., Mitchell, S. L., Clay, H. B., Reiss, S., Li, Z., and Murdock, D. G. (2013) The mitochondrial fatty acid synthesis (mtFASII) pathway is capable of mediating nuclear-mitochondrial cross talk through the PPAR system of transcriptional activation. Biochem. Biophys. Res. Commun. 441, 418-424
72. Schulte, U. (2001) Biogenesis of respiratory complex I. J. Bioenerg. Biomembr. 33, 205-212
73. Calvo, S. E., Compton, A. G., Hershman, S. G., Lim, S. C., Lieber, D. S., Tucker, E. J., Laskowski, A., Garone, C., Liu, S., Jaffe, D. B., Christodoulou, J., Fletcher, J. M., Bruno, D. L., Goldblatt, J., Dimauro, S., Thorburn, D. R., and Mootha, V. K. (2012) Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci. Transl. Med. 4, 118ra10